|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|
| Assets | ||||
| Current assets: | ||||
| Related party receivable | ||||
| Prepaid expenses | ||||
| Prepaid insurance | ||||
| Total Current Assets | ||||
| Non-current Assets | ||||
| Investments held in Trust Account | ||||
| Deferred offering costs | ||||
| Total Assets | ||||
| Liabilities, Ordinary shares subject to possible redemption and Shareholders’ Deficit | ||||
| Liabilities | ||||
| Current Liabilities | ||||
| Accrued expenses | ||||
| Accrued offering costs | ||||
| Due to Sponsors | ||||
| Promissory note – related party | ||||
| Related Party | ||||
| Total promissory note – related party | ||||
| Total Current Liabilities | ||||
| Deferred underwriting fee payable | ||||
| Total Liabilities | ||||
| Ordinary shares subject to possible redemption, 14,500,000 at a redemption value of $10.25 and $10.07 per share as of June 30, 2026 and December 31, 2025, respectively | ||||
| Shareholders’ Deficit | ||||
| Ordinary shares, value | ||||
| Class A Ordinary Shares | ||||
| Class B Ordinary Shares | ||||
| Additional paid-in capital | ||||
| Accumulated deficit | ||||
| Total Shareholders’ Deficit | ||||
| Total Liabilities, Ordinary shares subject to possible redemption and Shareholders’ Deficit |
Loading...
